You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 4, April 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Neurological Review
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cerebrotendinous Xanthomatosis

A Rare Disease With Diverse Manifestations

Mohammed H. Moghadasian, PhD; Gerald Salen, MD; Jiri J. Frohlich, MD; Charles H. Scudamore, MD

Arch Neurol. 2002;59:527-529.

This mini-review deals with a new appraisal of cerebrotendinous xanthomatosis. In addition to neurologic symptoms, patients with cerebrotendinous xanthomatosis develop cataracts, diarrhea, Achilles tendon xanthoma, atherosclerotic vascular disease, and many other abnormalities. Although the pathophysiology of the disease is not completely understood, excess production and consequent accumulation of cholestanol in tissues may play a crucial role. Chenodeoxycholic acid is the most effective therapy. The causative role and detrimental effects (at a low plasma level) of cholestanol merit further investigation.


From the Departments of Pathology and Laboratory Medicine (Drs Moghadasian and Frohlich) and Surgery (Dr Scudamore), University of British Columbia, Vancouver; and Departments of Medicine, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark (Dr Salen), and Veterans Affairs Medical Center, East Orange, NJ (Dr Salen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(4):655-656.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5
Goizet et al.
Brain 2009;132:1589-1600.
ABSTRACT | FULL TEXT  

Regulation of Human Vitamin D3 25-Hydroxylases in Dermal Fibroblasts and Prostate Cancer LNCaP Cells
Ellfolk et al.
Mol. Pharmacol. 2009;75:1392-1399.
ABSTRACT | FULL TEXT  

Achilles tendon enlargement and unsteady gait
Selva-O'Callghan et al.
Rheumatology (Oxford) 2007;46:1212-1213.
FULL TEXT  

Phenotypic heterogeneity of sitosterolemia
Wang et al.
J. Lipid Res. 2004;45:2361-2367.
ABSTRACT | FULL TEXT  

Transcriptional Regulation of Human CYP27 Integrates Retinoid, Peroxisome Proliferator-Activated Receptor, and Liver X Receptor Signaling in Macrophages
Szanto et al.
Mol. Cell. Biol. 2004;24:8154-8166.
ABSTRACT | FULL TEXT  

Cerebrotendinous Xanthomatosis: Juvenile Cataract and Chronic Diarrhea Before the Onset of Neurologic Disease
Cruysberg
Arch Neurol 2002;59:1975-1975.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.